Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,812 | 1,195 | 2,512 | 2,589 | 3,240 |
| Operating Income | -3,812 | -1,195 | -2,512 | -2,589 | -3,240 |
| Other Income | 34 | 63 | 79 | 106 | 167 |
| Pre-tax Income | -3,778 | -1,132 | -2,433 | -2,483 | -3,073 |
| Net Income Continuous | -3,778 | -1,132 | -2,433 | -2,483 | -3,073 |
| Net Income | $-3,778 | $-1,132 | $-2,433 | $-2,483 | $-3,073 |
| EPS Basic Total Ops | -21.00 | -6.30 | -13.56 | -14.04 | -17.82 |
| EPS Basic Continuous Ops | -21.04 | -6.31 | -13.57 | -13.98 | -17.80 |
| EPS Diluted Total Ops | -21.00 | -6.30 | -13.56 | -14.04 | -17.82 |
| EPS Diluted Continuous Ops | -21.04 | -6.31 | -13.57 | -13.98 | -17.80 |
| EPS Diluted Before Non-Recurring Items | -21.06 | -6.30 | -13.50 | -14.04 | N/A |
| EBITDA(a) | $-3,812 | $-1,195 | $-2,512 | $-2,589 | $-3,240 |